Nicox: appoints new Board Chairman
(CercleFinance.com) - On Tuesday Nicox announced the appointment of Damian Marron, a British biotech executive, as Chairman of the Board of Directors.
The French ophthalmology group states that Damian Marron succeeds
Jean-François Labbé, who has decided to retire at the end of his term.
Nicox says that Damian Marron has extensive industry experience, with a specialisation in immuno-oncology, cell therapy and orphan diseases.
He is currently Chairman of the Board of Directors of Circio Hodling, Imophoron and Indegra Therapeutics.
Nicox also informs that Marc Le Bozec, former CFO of Cellectis, has also joined its Board of Directors, also as an independent director.
The Board now includes Damian Marron (Chairman), Gavin Spencer (CEO), Michele Garufi and Marc Le Bozec.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The French ophthalmology group states that Damian Marron succeeds
Jean-François Labbé, who has decided to retire at the end of his term.
Nicox says that Damian Marron has extensive industry experience, with a specialisation in immuno-oncology, cell therapy and orphan diseases.
He is currently Chairman of the Board of Directors of Circio Hodling, Imophoron and Indegra Therapeutics.
Nicox also informs that Marc Le Bozec, former CFO of Cellectis, has also joined its Board of Directors, also as an independent director.
The Board now includes Damian Marron (Chairman), Gavin Spencer (CEO), Michele Garufi and Marc Le Bozec.
Copyright (c) 2024 CercleFinance.com. All rights reserved.